| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/28/2006 | CN1261453C Platelet-derived growth factor D, DNA coding and uses thereof |
| 06/28/2006 | CN1261446C Nucleotide specific for escherichia coli 0141 O-antigen |
| 06/28/2006 | CN1261445C Nucleotide specific for escherichia coli 0156 O-antigen |
| 06/28/2006 | CN1261444C Nucleotide specific for escherichia coli 054 O-antigen |
| 06/28/2006 | CN1261161C Compound interferon inducing agent lozenge |
| 06/28/2006 | CN1261160C Hybrid yeast AIDS vaccine |
| 06/27/2006 | US7067639 Method to provide bacterial ghosts provided with antigens |
| 06/27/2006 | US7067635 For use in diagnostic methods, immunotherapy, gene therapy and as vaccines |
| 06/27/2006 | US7067634 Method for diagnosing or monitoring carbohydrate metabolism disorders |
| 06/27/2006 | US7067630 Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof |
| 06/27/2006 | US7067626 Human ion channel proteins |
| 06/27/2006 | US7067496 Transplanting into dermis, least one hair follicle that has been modified ex vivo to contain nucleic acid molecule to introduce nucleic acid molecule into mammal |
| 06/27/2006 | US7067487 Amino acid sequence having homology with amino acid position 194 to 220 in a pestiviral Erns protein RNase, from 59-88 in a L3 loop of a cytotoxic RNase of a ribosome-inactivating protein, or 187- 223 in respiratory syncytial virus |
| 06/27/2006 | US7067472 Administering an OB-receptor agonist ligand (which is a recombinant human OB protein, also known as leptin) for conferring resistance to endotoxic shock in an animal in need of resistance to endotoxic shock |
| 06/27/2006 | US7067315 Parasiticides; immunoassays; microbiocides |
| 06/27/2006 | US7067310 Generation plasmid in prokaryotic cell; obtain cell, incubate with nucleotide sequences, transform cell, allow homologouus recombination to occur, recover recombinamt plasmid |
| 06/27/2006 | US7067283 via cells extracted from adenovirus-transferred kedney cell liver |
| 06/27/2006 | US7067281 Mammalian IAP gene family, primers, probes and detection methods |
| 06/27/2006 | US7067255 Hereditary hemochromatosis gene |
| 06/27/2006 | US7067247 Comprises mutant hepatitis B surface antigen for detecting viral diseases; immunoassays; kidney disorders |
| 06/27/2006 | US7067160 Three stage extraction using alcohol solvents |
| 06/27/2006 | US7067138 Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis |
| 06/27/2006 | US7067137 Method for treating post herpetic neuralgia by peripheral administration of a neurotoxin |
| 06/27/2006 | US7067136 Proteins; gene expression of antigen in vivo; genetic engineering; detection of antibiotics ; drug design; plasmids |
| 06/27/2006 | US7067135 RAP (RNAIII activating protein) polypeptide of amino acid sequence 13 |
| 06/27/2006 | US7067134 Viricides; genetic engineering; replacing envelope glycoproteins with signal sequence; removal nef gene |
| 06/27/2006 | US7067133 Expression vector encoding a fusion protein with segments of a region which binds to an epitope or fragment and fragment or whole proteins that can cross the blood brain barrier |
| 06/27/2006 | US7067132 Binding to muteins; prevent signal transduction; monoclonal antibodies; graft versus host disease; antiarthritic agents; antidiabetic agents; skin disorders; autoimmune disease; inflammatory bowel disorders; anticancer agents |
| 06/27/2006 | US7067131 Methods for using anti-MUC18 antibodies |
| 06/27/2006 | US7067130 Genetic engineering; polypeptide; cancer diagnosis |
| 06/27/2006 | US7067129 Receptor specific transepithelial transport in therapeutics |
| 06/27/2006 | US7067128 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 06/27/2006 | US7067120 Cytokine gene modified antigen-presenting cell/tumor cell conjugate, its preparation and use |
| 06/27/2006 | US7067119 Using polypeptides |
| 06/27/2006 | US7067118 Methods of using mutant flt3-ligand polypeptides to induce cellular expansion |
| 06/27/2006 | US7067110 Immunoglobulin, antigen bonded to polypeptides; modulate immunology response |
| 06/27/2006 | US7067109 Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids |
| 06/27/2006 | CA2195935C Streptococcus equi vaccine |
| 06/22/2006 | WO2006066229A2 Elicitation of antibodies to self peptides by immunization with dendritic cells |
| 06/22/2006 | WO2006066214A2 Use of flagellin in the immunotherapy of yersinia pestis |
| 06/22/2006 | WO2006066171A1 Amyloid βετα antibodies for use in improving cognition |
| 06/22/2006 | WO2006066089A1 Humanized amyloid beta antibodies for use in improving cognition |
| 06/22/2006 | WO2006066086A1 Antiangiogenesis therapy of autoimmune disease in patients who have failed prior therapy |
| 06/22/2006 | WO2006066078A2 Fcϝriib-specific antibodies and methods of use thereof |
| 06/22/2006 | WO2006066065A2 Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising this fragment for detecting, preventing, and treating hiv |
| 06/22/2006 | WO2006065975A2 Methods of treating ankylosing spondylitis using anti-tnf antibodies and peptides of human tumor necrosis factor |
| 06/22/2006 | WO2006065888A2 Targeted iron chelator delivery system |
| 06/22/2006 | WO2006065821A2 Improved dna immunization with recombinase/transposase |
| 06/22/2006 | WO2006065780A2 Combinations of therapeutic agents for treating cancer |
| 06/22/2006 | WO2006065746A2 Methods of treating ige-mediated disorders comprising the administration of high concentration anti-ige antibody formulations |
| 06/22/2006 | WO2006065549A2 Attenuated vaccine useful for immunizations against coccidioides spp. infections |
| 06/22/2006 | WO2006065395A1 Compositions comprising sclareol or derivatives thereof and uses thereof |
| 06/22/2006 | WO2006065166A1 Protein l1 and protein e7 peptide-based composition for treating and preventing a human papillomaviral infection |
| 06/22/2006 | WO2006064983A1 Monoclonal antibody specific human embryonic stem cell |
| 06/22/2006 | WO2006064861A1 Function inhibitor of adam10 or adam17 protein and method of screening the same |
| 06/22/2006 | WO2006064449A1 Detoxifying and immunity-booster composition |
| 06/22/2006 | WO2006064378A2 Adjuvant activity of gastrointestinal peptides |
| 06/22/2006 | WO2006064121A2 Cytotoxic antibody directed against type b lymphoid hematopoietic proliferations |
| 06/22/2006 | WO2006063974A2 Il-15 antigen arrays and uses thereof |
| 06/22/2006 | WO2006063800A1 Cloning of honey bee allergen |
| 06/22/2006 | WO2006063592A1 Pharmaceutical composition comprising a bacterial cell displaying a heterologous proteinaceous compound |
| 06/22/2006 | WO2006063523A1 A polyvalent attenuated live vaccine for preventing and curing vibriosis of cultivated fish |
| 06/22/2006 | WO2006063445A1 Recombinant foot and mouth disease vaccine |
| 06/22/2006 | WO2006063415A1 Regulation of metalloprotease cleavage of cell surface proteins |
| 06/22/2006 | WO2006042158A3 Methods and compositions for improving recombinant protein production |
| 06/22/2006 | WO2006040047A3 Diagnostics and therapeutics for diseases associated with rho/rac-interacting citron kinase (cit) |
| 06/22/2006 | WO2006038129A3 Hepatitis c virus replication system |
| 06/22/2006 | WO2006032525B1 Combinational therapy for treating cancer |
| 06/22/2006 | WO2006032500A3 Immunogenic composition |
| 06/22/2006 | WO2006027699A3 Rnaiii-inhibiting peptides for treating hiv infection |
| 06/22/2006 | WO2006023649A3 Treatment of severe multiple sclerosis |
| 06/22/2006 | WO2006010514A3 Diagnostics and therapeutics for diseases associated with dual specificity mitogen-activated protein kinase kinase 5 (map2k5) |
| 06/22/2006 | WO2006010498A3 Diagnostics and therapeutics for diseases associated with methionine aminopeptidase 2 (metap2) |
| 06/22/2006 | WO2006008008A3 Diagnostics and therapeutics for diseases associated with hepatocyte nuclear factor 4, alpha (hnf4a) |
| 06/22/2006 | WO2006004910A9 Improved bispecific antibodies |
| 06/22/2006 | WO2005121177A3 Anti-il-13 antibodies, crystals of anti-il-13 antibodies and complexes comprising them |
| 06/22/2006 | WO2005118887A3 Human antibodies interacting with hiv gp41 |
| 06/22/2006 | WO2005117996A3 Immune response assessment method |
| 06/22/2006 | WO2005117978A3 Method for treating multiple sclerosis |
| 06/22/2006 | WO2005115130A3 Transgenic ficus, method for producing same and use thereof |
| 06/22/2006 | WO2005113005A3 Transcutaneous and/or transdermal transport of materials |
| 06/22/2006 | WO2005110481A3 Prolongation of survival of an allograft by inhibiting complement activity |
| 06/22/2006 | WO2005108626A3 Mutants of staphylococcal mrs and methods of use |
| 06/22/2006 | WO2005106002A3 Polyvalent viral vectors and a system for production thereof |
| 06/22/2006 | WO2005101004A8 Diagnostics and therapeutics for diseases associated with purinoceptor 1 type y (p2y1) |
| 06/22/2006 | WO2005095953A3 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor type 6 (ccr6) |
| 06/22/2006 | WO2005091853A3 Methods and compositions for treating il-13 related pathologies |
| 06/22/2006 | WO2005091751A3 Novel gene associated with type 1 diabetes and methods of use |
| 06/22/2006 | WO2005089101A3 Non-pathogenic listeria vaccine vectors and methods of treatment therewith |
| 06/22/2006 | WO2005085867A8 Screening method for emulators of neural activity and digestive system using gpr35 |
| 06/22/2006 | WO2005062955A3 Agonist anti-trkc antibodies and methods using same |
| 06/22/2006 | WO2005028665A3 Campylobacter polypeptides and methods of use |
| 06/22/2006 | WO2004101738A3 Domain-exchanged binding molecules, methods of use and methods of production |
| 06/22/2006 | WO2004056318A8 Method for treating amyloid disease |
| 06/22/2006 | WO2004052276A3 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 06/22/2006 | WO2004032868A3 Methods of treating alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof |
| 06/22/2006 | US20060136148 Efficient algorithm for PCR testing of blood samples |
| 06/22/2006 | US20060136136 Crystal structure of baff, and use thereof in drug design |
| 06/22/2006 | US20060135906 Iontophoretic device and method for administering immune response-enhancing agents and compositions |
| 06/22/2006 | US20060135749 Cd47 partal peptdie and anti-shps-1 monoclonal antibody |